-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Sinopharm Group has been accepted by CDE for its marketing application for doxofylline injection, which is a generic type 4 application, which is used to treat bronchitis and other diseases
Doxofylline is a derivative of methylxanthine.
According to data from Minet.
Sales of terminal doxofylline injection in Chinese public medical institutions (unit: ten thousand yuan)
Source: Minet.
Up to now, doxofylline injection has been reviewed by 14 companies, including Fuhe Pharmaceutical, Fuan Pharmaceutical, Yangzijiang, Shijiazhuang No.
Data source: Minet database